27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Twist Bioscience Corporation (NASDAQ:TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies.
- Financial and other details of the partnership were not disclosed.
- Under the terms of the agreement, Twist plans to identify antibodies against targets coming out of SomaLogic's SomaScan proteomics platform.
- "Having access to the SomaScanplatform provides a rich source of clinically relevant biomarkers in diverse therapeutic areas, where we can then take those targets and discover potent antibodies for the treatment of disease," Twist CEO and Cofounder Emily Leproust said in a statement.
- In March, SomaLogic announced it would go public through a merger with a special purpose acquisition company, a transaction that is expected to close this quarter.
- Price Action: TWST shares are up 1.88% at $99.17 during the market session on the last check Wednesday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!